California - AACE 18th Annual Meeting & Symposium

Marina del Rey, CA US
September 14, 2018 to September 16, 2018

Welcome, and thank you for attending the California AACE 18th Annual Meeting & Symposium

The California Chapter of AACE program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease.

This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.

Providing exceptional patient care requires continuing high quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.

http://syllabus.aace.com/2018/Chapters/California/index.html

Target Audience

Endocrinologists, MD/DOs, advanced practice clinicians, and other healthcare professionals living in or around the state of California who practice, or are interested in, the treatment of endocrine disease states.

Learning Objectives

  1. Cite the bariatric surgery long-term glycemic outcomes in patients with T2DM
  2. Recognize the CVD risk factors improved by bariatric surgery
  3. Identify which patients with cardio-metabolic risk are most likely to benefit from bariatric surgery
  4. Appropriately use stage, recurrence risk and response to therapy in patient care
  5. Know when to reduce monitoring intensity and intervals in patients with excellent or indeterminate responses to therapy
  6. Appropriately apply monitoring, directed therapy and systemic therapy to patients with persistent disease
  7. Utilize ultrasound to guide extent of initial surgery for differentiated thyroid cancer
  8. Describe how recent changes in diagnostic technology and practice guidelines have influenced surgery for differentiated thyroid cancer
  9. Understand how changes in surgical management will affect surveillance strategies for differentiated thyroid cancer
  10. Understand how Center of Excellence approach can enhance outcomes
  11. Know some of the nuances of the endoscopic pituitary surgical technique
  12. Realize potential complications of endoscopic pituitary surgery
  13. Understand the means to diagnose hypoparathyroidism
  14. Understand the approach to treatment of hypoparathyroidism
  15. Understand the role of PTH replacement therapy
  16. Recognize the physiologic roles of vitamin D and calcium in bone health
  17. Know how much vitamin D to recommend to patients with osteoporosis
  18. Know how much calcium to recommend to patients with osteoporosis
  19. Be familiar with the updated AACE Guidelines for osteoporosis
  20. Understand when "drug holidays" are appropriate
  21. Appreciate the effects of different sequences of osteoporosis drugs
  22. Review the latest technology relating to CGM for people with type 1 diabetes
  23. Understand the role of CGM in type 2 diabetes
  24. Be able to discuss the advances in the artificial pancreas
  25. Understand the physiology of GLP-1
  26. Review non-glucose/insulin related effects of GLP-1
  27. Discuss theories on how GLP-1 agonist provides the cardiovascular benefits observed in the CVOT
  28. Understand the role of the adrenal axis in the acute versus chronic stress response
  29. Recognize maladaptive patterns in chronic stress that contribute to symptoms of fatigue
  30. Identify the role of mind-body therapies and integrative approaches to manage chronic stress
  31. Changes in ADA recommendations in Obesity Management
  32. Literature on Lifestyle modification and management of pre-diabetes/T2DM
  33. Literature on bariatric surgery and management of pre-diabetes/T2DM
Additional information
Available for MOC Points?: 
No
Practice Area: 
Adrenal
Diabetes
Nutrition
Obesity
Thyroid
Endo Surgery
Course summary
Available credit: 
  • 10.25 AMA
  • 10.25 Attendance
Course opens: 
09/15/2018
Course expires: 
09/16/2019
Event starts: 
09/14/2018 - 7:00pm
Event ends: 
09/16/2018 - 12:00pm
Cost:
$0.00

THE RITZ-CARLTON, MARINA DEL REY
4375 ADMIRALTY WAY
MARINA DEL REY, CA 90292

FRIDAY, SEPTEMBER 14, 2018

7:00 – 9:00 PM

Welcome Reception

SATURDAY, SEPTEMBER 15, 2018

7:00 – 8:00 AM

Registration & Breakfast

8:00 – 8:10 AM

Welcoming Remarks
Jennifer Han, MD, FACE; Program Co-Chair; Jaiwant Rangi, MD, FACE; Program Co-Chair;
Michael Bush, MD; CA AACE President

8:10 – 8:20 AM

Pre-Meeting Assessment

8:20 – 9:05 AM

The Role of Bariatric Surgery in Patients with T2DM and CVD Risk
Dan Hurley, MD, FACE
Objectives

  1. Cite the bariatric surgery long-term glycemic outcomes in patients with T2DM
  2. Recognize the CVD risk factors improved by bariatric surgery
  3. Identify which patients with cardio-metabolic risk are most likely to benefit from bariatric surgery
9:05 – 9:15 AM

Question & Answer

9:15 – 10:00 AM

Surveillance and Management of Persistent or Recurrent Thyroid Cancer
Bryan Haugen, MD
Objectives

  1. Appropriately use stage, recurrence risk and response to therapy in patient care
  2. Know when to reduce monitoring intensity and intervals in patients with excellent or indeterminate responses to therapy
  3. Appropriately apply monitoring, directed therapy and systemic therapy to patients with persistent disease
10:00 – 10:10 AM

Question & Answer

10:10 – 10:40 AM

Break

10:40 – 11:25 AM

Thyroid Cancer Surgery Updates
Michael Yeh, MD, FACE
Objectives

  1. Utilize ultrasound to guide extent of initial surgery for differentiated thyroid cancer
  2. Describe how recent changes in diagnostic technology and practice guidelines have influenced surgery for differentiated thyroid cancer
  3. Understand how changes in surgical management will affect surveillance strategies for differentiated thyroid cancer
11:25 – 11:35 AM

Question & Answer

11:35 – 11:55 AM

CA AACE Business Meeting

11:55 – 1:00 PM

Lunch / Fellows Meeting

1:00 – 1:50 PM

Optimizing Outcomes in Pituitary Surgery: Importance of multidisciplinary approach 
Daniel F. Kelly, MD
Objectives

  1. Understand how Center of Excellence approach can enhance outcomes
  2. Know some of the nuances of the endoscopic pituitary surgical technique
  3. Realize potential complications of endoscopic pituitary surgery
1:50 – 2:00 PM

Question & Answer

2:00 – 5:00 PM

Symposium: “Calcium”

2:00 – 2:40 PM

Hypoparathyroidism - Diagnosis, Prevention and Treatment Options
Dolores Shoback, MD
Objectives

  1. Understand the means to diagnose hypoparathyroidism
  2. Understand the approach to treatment of hypoparathyroidism
  3. Understand the role of PTH replacement therapy
2:40 – 3:20 PM

Vitamin D and Calcium Supplementation in Osteoporosis
Albert Shieh, MD, MS
Objectives

  1. Recognize the physiologic roles of vitamin D and calcium in bone health
  2. Know how much vitamin D to recommend to patients with osteoporosis
  3. Know how much calcium to recommend to patients with osteoporosis
3:20 – 3:40 PM

Break

3:40 – 4:20 PM

Current Issues in Osteoporosis
Michael R. McClung, MD, FACP, FACE
Objectives

  1. Be familiar with the updated AACE Guidelines for osteoporosis
  2. Understand when "drug holidays" are appropriate
  3. Appreciate the effects of different sequences of osteoporosis drugs
4:20 – 4:50 PM

Symposium Q & A / Panel Discussion

4:50 – 5:00 PM

Post Meeting Assessment

5:00 – 6:00 PM

Reception

SUNDAY, SEPTEMBER 16, 2018

7:00 – 8:00 AM

Continental Breakfast

8:00 – 8:10 AM

Pre Meeting Assessment

8:10 – 8:50 AM

Advances in Continuous Glucose Monitoring for Type 1 and Type 2 Diabetes
Steve Edelman, MD
Objectives

  1. Review the latest technology relating to CGM for people with type 1 diabetes
  2. Understand the role of CGM in type 2 diabetes
  3. Be able to discuss the advances in the artificial pancreas
8:50 – 9:00 AM

Question & Answer

9:00 – 9:40 AM

GLP-1 Receptor Agonists
George Grunberger, MD, FACP, FACE
Objectives

  1. Understand the physiology of GLP-1
  2. Review non-glucose/insulin related effects of GLP-1
  3. Discuss theories on how GLP-1 agonist provides the cardiovascular benefits observed in the CVOT
9:40 – 9:50 AM

Question & Answer

9:50 – 10:05 AM

Break

10:05 – 10:45 AM

Adrenal Fatigue: An integrative endocrinologist's perspective
Rashmi Mullur, MD
Objectives

  1. Understand the role of the adrenal axis in the acute versus chronic stress response
  2. Recognize maladaptive patterns in chronic stress that contribute to symptoms of fatigue
  3. Identify the role of mind-body therapies and integrative approaches to manage chronic stress
10:45 – 10:55 AM

Question & Answer

10:55 – 11:35 AM

Treating Pre-Diabetes and Type 2 Diabetes through Obesity Management
Vijaya Surampudi, MD, MS
Objectives

  1. Changes in ADA recommendations in Obesity Management
  2. Literature on Lifestyle modification and management of pre-diabetes/T2DM
  3. Literature on bariatric surgery and management of pre-diabetes/T2DM
11:35 – 11:45 AM

Question & Answer

11:45 – 12:00 PM

Post Meeting Assessment

12:00 PM

Closing Remarks & Adjournment

The Ritz-Carlton, Marina del Rey
4375 Admiralty Way
Marina del Rey, CA 90292
United States

Steven Edelman, MD
Professor of Medicine
University of California San Diego
Veterans Affairs Medical Center
Founder and Director Taking Control of Your Diabetes 501(c)3
San Diego, CA

George Grunberger, MD, FACP, FACE
Chairman, Grunberger Diabetes Institute
Clinical Professor, Internal Medicine and Molecular Medicine & Genetics
Wayne State University School of Medicine
Professor, Internal Medicine
Oakland University William Beaumont School of Medicine
Visiting Professor
First Faculty of Medicine, Charles University, Prague
Bloomfield Hills, MI

Bryan R. Haugen, MD
Professor of Medicine and Pathology
Head, Division of Endocrinology, Metabolism and Diabetes
Mary Rossick Kern and Jerome H. Kern Chair and Endocrine Neoplasm Research
University of Colorado School of Medicine
Aurora, CO

Daniel L. Hurley, MD, FACE
Associate Professor of Medicine
Mayo Clinic
Rochester, MN

Daniel F. Kelly, MD
Director, Pacific Neuroscience Institute
Professor of Neurosurgery, John Wayne Cancer Institute
Providence Saint John's Health Center
Santa Monica, CA

Michael R. McClung, MD, FACP, FACE
Founding Director
Oregon Osteoporosis Center
Portland, OR

Rashmi Mullur, MD
Associate Chief of Integrative Medicine
VA Greater Los Angeles Health System
Assistant Professor of Medicine
David Geffen School of Medicine at UCLA
Santa Monica, CA

Albert Shieh, MD, MS
Clinical Instructor
University of California, Los Angeles
Department of Medicine
Division of Endocrinology
Division of Geriatrics
Los Angeles, CA

Dolores Shoback, MD
Professor of Medicine
University of California, San Francisco
San Francisco, CA

Vijaya Surampudi, MD, MS
Assistant Professor of Medicine
Center of Human Nutrition
University of California Los Angeles
Los Angeles, CA

Michael Yeh, MD, FACE
Professor of Surgery and Medicine
Chief, Section of Endocrine Surgery
UCLA David Geffen School of Medicine
Los Angeles, CA

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists (AACE) and the California Chapter of AACE. The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 10.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 10.25 AMA
  • 10.25 Attendance

Accreditation Period

Course opens: 
09/15/2018
Course expires: 
09/16/2019

Price

Cost:
$0.00
Please login or register to take this course.